Application

17100528 · DIARYL AND ARYLHETEROARYL UREA DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF HALLUCINATIONS ASSOCIATED WITH A NEURODEGENERATIVE DISEASE

Filed 2020-11-20 · Granted · Patent 11304932 (2022-04-19) The official file ↗The patent and its PDF ↗ · Art unit 1626 · Examiner Kristin Ann Vajda Easy · CPC A61K 31/415 · Axovant Sciences GmbH · FISH & RICHARDSON P.C. (ARENA PHARMACEUTICALS)